MedTrace Logo

Evaluation of Quality of Vision and Spectacle Independence With the AcrySof® Panoptix® Intraocular Lens

NCT04124952 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-11-22

Study results available
· View outcomes & findings →

Summary

This is a study to assess the spectacle independence and quality of vision of patients receiving the AcrySof® Panoptix® Intraocular lens (IOL) after uneventful cataract surgery.

Conditions

  • Cataract

Interventions

DEVICE

Panoptix

Alcon Acrysof(R) Panoptix(R) intraocular lens (IOL)

Sponsors & Collaborators

  • Science in Vision

    collaborator OTHER

  • SightTrust Eye Institute

    lead OTHER

Principal Investigators

  • Andrew C Shatz, MD · SightTrust Eye Institute

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-03
Primary Completion
2021-02-16
Completion
2021-02-16
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04124952 on ClinicalTrials.gov